Russell Investments Group Ltd. Sells 7,127 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Russell Investments Group Ltd. lowered its holdings in Addus HomeCare Co. (NASDAQ:ADUSGet Rating) by 37.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 11,736 shares of the company’s stock after selling 7,127 shares during the period. Russell Investments Group Ltd. owned approximately 0.07% of Addus HomeCare worth $1,094,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of ADUS. Silvercrest Asset Management Group LLC raised its position in shares of Addus HomeCare by 570.1% in the fourth quarter. Silvercrest Asset Management Group LLC now owns 770,538 shares of the company’s stock valued at $71,648,000 after purchasing an additional 655,548 shares during the period. Summit Creek Advisors LLC grew its stake in Addus HomeCare by 28.2% during the fourth quarter. Summit Creek Advisors LLC now owns 211,218 shares of the company’s stock valued at $19,751,000 after acquiring an additional 46,459 shares in the last quarter. Assenagon Asset Management S.A. purchased a new position in Addus HomeCare during the first quarter valued at approximately $4,244,000. Northern Trust Corp grew its stake in Addus HomeCare by 10.4% during the fourth quarter. Northern Trust Corp now owns 285,427 shares of the company’s stock valued at $26,690,000 after acquiring an additional 26,787 shares in the last quarter. Finally, Invesco Ltd. grew its stake in Addus HomeCare by 5.5% during the fourth quarter. Invesco Ltd. now owns 495,263 shares of the company’s stock valued at $46,313,000 after acquiring an additional 25,624 shares in the last quarter. Institutional investors own 96.04% of the company’s stock.

Insider Transactions at Addus HomeCare

In other news, Director Esteban Lopez sold 1,100 shares of the business’s stock in a transaction that occurred on Monday, August 15th. The shares were sold at an average price of $95.00, for a total value of $104,500.00. Following the completion of the sale, the director now directly owns 2,064 shares in the company, valued at approximately $196,080. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, EVP Sean Gaffney sold 10,000 shares of the company’s stock in a transaction on Thursday, August 4th. The shares were sold at an average price of $95.00, for a total transaction of $950,000.00. Following the completion of the sale, the executive vice president now directly owns 14,413 shares in the company, valued at approximately $1,369,235. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Esteban Lopez sold 1,100 shares of the company’s stock in a transaction on Monday, August 15th. The shares were sold at an average price of $95.00, for a total transaction of $104,500.00. Following the sale, the director now owns 2,064 shares of the company’s stock, valued at $196,080. The disclosure for this sale can be found here. In the last ninety days, insiders sold 31,013 shares of company stock worth $2,898,765. 4.50% of the stock is currently owned by insiders.

Addus HomeCare Price Performance

ADUS stock opened at $95.49 on Friday. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.00 and a quick ratio of 2.00. Addus HomeCare Co. has a one year low of $68.57 and a one year high of $108.11. The stock has a market cap of $1.54 billion, a PE ratio of 34.60, a P/E/G ratio of 2.55 and a beta of 0.85. The firm has a 50 day simple moving average of $88.30 and a two-hundred day simple moving average of $84.32.

Addus HomeCare (NASDAQ:ADUSGet Rating) last announced its quarterly earnings data on Monday, August 1st. The company reported $0.91 earnings per share for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.01). The business had revenue of $236.94 million during the quarter, compared to the consensus estimate of $238.40 million. Addus HomeCare had a return on equity of 8.63% and a net margin of 4.90%. The company’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.78 earnings per share. On average, analysts predict that Addus HomeCare Co. will post 3.18 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on ADUS shares. Stephens reduced their price objective on shares of Addus HomeCare from $110.00 to $101.00 and set an “overweight” rating for the company in a research note on Tuesday, June 21st. StockNews.com raised shares of Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research note on Friday, August 12th. Royal Bank of Canada reduced their price objective on shares of Addus HomeCare from $111.00 to $110.00 and set an “outperform” rating for the company in a research note on Wednesday, August 3rd. Oppenheimer cut their price target on shares of Addus HomeCare from $135.00 to $130.00 and set an “outperform” rating for the company in a research note on Wednesday, August 3rd. Finally, Stifel Nicolaus started coverage on shares of Addus HomeCare in a research note on Tuesday, June 28th. They issued a “buy” rating and a $101.00 price target for the company. Five research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $110.40.

About Addus HomeCare

(Get Rating)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health.

Recommended Stories

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Co. (NASDAQ:ADUSGet Rating).



Receive News & Ratings for Addus HomeCare Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Addus HomeCare and related companies with MarketBeat.com’s FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *